Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

References

• Vierk KA, Koehler KM, Fein SB, Street DA. Prevalence of self-reported food allergy in American adults and use of food labels. J Allergy Clin Immunol 2007; 119(6):1504-10; PMID:17451802; https://doi.org/10.1016/j.jaci.2007.03.011
   PubMed Web of Science ®Google Scholar
• Vesikari T, Block SL, Guerra F, Lattanzi M, Holmes S, Izu A, Gaitatzis N, Hilbert AK, Groth N. Immunogenicity, Safety, and Reactogenicity of a Mammalian Cell-Culture-Derived Influenza Vaccine in Healthy Children and Adolescents 3 to 17 Years of Age. Pediatr Infect Dis J 2012; 31(5):494-500; PMID:22301476; https://doi.org/10.1097/INF.0b013e31824bb179
   PubMed Web of Science ®Google Scholar
• Kida H, Webster RG, Yanagawa R. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus. Arch Virol 1983; 76(2):91-9; PMID:6191738; https://doi.org/10.1007/BF01311693
   PubMed Web of Science ®Google Scholar
• Yoden S, Kida H, Kuwabara M, Yanagawa R, Webster RG. Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Virus Res 1986; 4(3):251-61; PMID:3017016; https://doi.org/10.1016/0168-1702(86)90004-3
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary. Washington (DC): National Academies Press (US); 2010; PMID:22171399; https://doi.org/10.17226/12856
   Google Scholar
• Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok(R)) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine 2011; 29(44):7733-9; PMID:21835220; https://doi.org/10.1016/j.vaccine.2011.07.128
   PubMed Web of Science ®Google Scholar
• Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H, Perdue ML. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 1999; 17(18):2265-74; PMID:10403594; https://doi.org/10.1016/S0264-410X(98)00494-0
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, O'Brien D, Wolff M, Rabinovich G, Blackwelder W, Katz JM. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 2001; 19(13–14):1732-7; PMID:11166898; https://doi.org/10.1016/S0264-410X(00)00395-9
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004; 82(5):488-96; PMID:15479434; https://doi.org/10.1111/j.0818-9641.2004.01272.x
   PubMed Web of Science ®Google Scholar
• Cooper PD, Petrovsky N. Delta inulin: a novel, immunologically active, stable packing structure comprising beta-D-[2 ->1] poly(fructo-furanosyl) alpha-D-glucose polymers. Glycobiology 2011; 21(5):595-606; PMID:21147758; https://doi.org/10.1093/glycob/cwq201
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Kolpe A, Li L, Petrovsky N. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection. Vaccine 2014; 32(36):4651-9; PMID:24958701; https://doi.org/10.1016/j.vaccine.2014.06.057
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Ong CH, Petrovsky N. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection. Vaccine 2015; 33(38):4892-900; PMID:26232344; https://doi.org/10.1016/j.vaccine.2015.07.051
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Saade F, Petrovsky N. Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine 2012; 30(36):5373-81; PMID:22728225; https://doi.org/10.1016/j.vaccine.2012.06.021
   PubMed Web of Science ®Google Scholar
• Saade F, Honda-Okubo Y, Trec S, Petrovsky N. A novel hepatitis B vaccine containing Advax, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing. Vaccine 2013; PMID:23306367
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Tseng CT, Petrovsky N. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol 2015; 89(6):2995-3007; PMID:25520500; https://doi.org/10.1128/JVI.02980-14
   PubMed Web of Science ®Google Scholar
• Bielefeldt-Ohmann H, Prow NA, Wang W, Tan CS, Coyle M, Douma A, Hobson-Peters J, Kidd L, Hall RA, Petrovsky N. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals. Vet Res 2014; 45:130; PMID:25516480; https://doi.org/10.1186/s13567-014-0130-7
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Larena M, Siddharthan V, Prow NA, Hall RA, Lobigs M, Morrey J. An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody. J Virol 2013; 87(18):10324-33; PMID:23864620; https://doi.org/10.1128/JVI.00480-13
   PubMed Web of Science ®Google Scholar
• Wong TM, Petrovsky N, Bissel SJ, Wiley CA, Ross TM. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Hum Vaccin Immunother 2016; 12(8):2096-2105, 1–10; PMID:27215855; https://doi.org/10.1080/21645515.2016.1162931
   PubMed Web of Science ®Google Scholar
• Feinen B, Petrovsky N, Verma A, Merkel TJ. Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant. Clin Vaccine Immunol 2014; 21(4):580-6; PMID:24554695; https://doi.org/10.1128/CVI.00019-14
   PubMed Web of Science ®Google Scholar
• Rodriguez-Del Rio E, Marradi M, Calderon-Gonzalez R, Frande-Cabanes E, Penadés S, Petrovsky N, Alvarez-Dominguez C. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax delta inulin adjuvant induces robust T-cell protection against listeria infection. Vaccine 2015; 33(12):1465-73; PMID:25659269; https://doi.org/10.1016/j.vaccine.2015.01.062
   PubMed Web of Science ®Google Scholar
• Cristillo AD, Ferrari MG, Hudacik L, Lewis B, Galmin L, Bowen B, Thompson D, Petrovsky N, Markham P, Pal R. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. J Gen Virol 2011; 92(Pt 1):128-40; PMID:21169215; https://doi.org/10.1099/vir.0.023242-0
   PubMed Web of Science ®Google Scholar
• Cosseddu GM, Polci A, Pinoni C, Capobianco Dondona A, Iapaolo F, Orsini G, Izzo F, Bortone G, Ronchi FG, Di Ventura M, et al. Evaluation of humoral response and protective efficacy of an inactivated vaccine against Peste des Petits Ruminants virus in goats. Transbound Emerg Dis 2016; 63(5):e447-52; PMID:25594237; https://doi.org/10.1111/tbed.12314
   Web of Science ®Google Scholar
• Petrovsky N, Cooper PD. Advax, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety. Vaccine 2015; 33(44):5920-6; PMID:26407920; https://doi.org/10.1016/j.vaccine.2015.09.030
   PubMed Web of Science ®Google Scholar
• Layton RC, Petrovsky N, Gigliotti AP, Pollock Z, Knight J, Donart N, Pyles J, Harrod KS, Gao P, Koster F. Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets. Vaccine 2011; 29(37):6242-51; PMID:21736913; https://doi.org/10.1016/j.vaccine.2011.06.078
   PubMed Web of Science ®Google Scholar
• Gordon D, Kelley P, Heinzel S, Cooper P, Petrovsky N. Immunogenicity and safety of Advax, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study. Vaccine 2014; 32(48):6469-77, Sep 27. pii: S0264-410X(14)01293-6; PMID:25267153; https://doi.org/10.1016/j.vaccine.2014.09.034
   PubMed Web of Science ®Google Scholar
• Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant. Vaccine 2016; 34(33):3780-6; PMID:27342914; https://doi.org/10.1016/j.vaccine.2016.05.071
   PubMed Web of Science ®Google Scholar
• Heddle R, Russo P, Petrovsky N, Hanna R, Smith A. Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy. World Allergy Organ J 2013; 6(Suppl 1):P158-P158; https://doi.org/10.1186/1939-4551-6-S1-P158
   Google Scholar
• Cohen J, Enserink M. Swine flu. After delays, WHO agrees: the 2009 pandemic has begun. Science 2009; 324(5934):1496-7; PMID:19541958; https://doi.org/10.1126/science.324_1496
   PubMed Web of Science ®Google Scholar
• Effectiveness of 2008–09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. MMWR Morb Mortal Wkly Rep 2009; 58(44):1241-5; PMID:19910912
   PubMedGoogle Scholar
• Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller MA. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361(7):674-9; PMID:19564633; https://doi.org/10.1056/NEJMoa0904023
   PubMed Web of Science ®Google Scholar
• Rajapaksha H, Petrovsky N. In silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies. PLoS One 2014; 9(7):e102618; PMID:25047593; https://doi.org/10.1371/journal.pone.0102618
   PubMed Web of Science ®Google Scholar
• Barclay TG, Rajapaksha H, Thilagam A, Qian G, Ginic-Markovic M, Cooper PD, Gerson A, Petrovsky N. Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation. Carbohydr Polym 2016; 143:108-15; PMID:27083349; https://doi.org/10.1016/j.carbpol.2016.01.062
   PubMed Web of Science ®Google Scholar
• Webster RG, Cox N, Stöhr K. WHO Manual on Animal Influenza Diagnosis and Surveillance (WHO/CDS/CSR/NCS/2002.5). 2002; Rev. 1:p37-9. Available from: http://www.who.int/iris/handle/10665/68026
   Google Scholar
• Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, Cox MM, Heinzel S, Petrovsky N. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax polysaccharide adjuvant. Vaccine 2012; 30(36):5407-16; PMID:22717330; https://doi.org/10.1016/j.vaccine.2012.06.009
   PubMed Web of Science ®Google Scholar
• Tan S, Gordon DL, Honda-Okubo Y, Petrovsky N, Phillips P, Huddleston S, Sadlon TA. Serological responses following influenza A H1N1 2009 infection in adults. J Infect 2011; 62(5):388-93; PMID:21420426; https://doi.org/10.1016/j.jinf.2011.03.002
   PubMed Web of Science ®Google Scholar
• He W, Mullarkey CE, Miller MS. Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay. Methods 2015; 90:95-100; PMID:25957674; https://doi.org/10.1016/j.ymeth.2015.04.037
   PubMed Web of Science ®Google Scholar
• Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, Zhang XF, Pan HX, Meng FY, Hu YM, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361(25):2414-23; PMID:19846844; https://doi.org/10.1056/NEJMoa0908535
   PubMed Web of Science ®Google Scholar
• Li L, Honda-Okubo Y, Li C, Sajkov D, Petrovsky N. Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell affinity maturation in human subjects receiving seasonal influenza vaccine. PLoS One 2015; 10(7):e0132003; PMID:26177480; https://doi.org/10.1371/journal.pone.0132003
   PubMed Web of Science ®Google Scholar
• Stephenson I, Das RG, Wood JM, Katz JM. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 2007; 25(20):4056-63; PMID:17412461; https://doi.org/10.1016/j.vaccine.2007.02.039
   PubMed Web of Science ®Google Scholar
• Verschoor CP, Singh P, Russell ML, Bowdish DM, Brewer A, Cyr L, Ward BJ, Loeb M. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children. PLoS One 2015; 10(6):e0131531; PMID:26107625; https://doi.org/10.1371/journal.pone.0131531
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012; 18(2):274-80; PMID:22286307; https://doi.org/10.1038/nm.2612
   PubMed Web of Science ®Google Scholar
• Langley JM, Risi G, Caldwell M, Gilderman L, Berwald B, Fogarty C, Poling T, Riff D, Baron M, Frenette L, et al. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis 2011; 203(12):1729-38; PMID:21606531; https://doi.org/10.1093/infdis/jir172
   PubMed Web of Science ®Google Scholar
• Geeraedts F, Bungener L, Pool J, ter Veer W, Wilschut J, Huckriede A. Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs. Influenza Other Respi Viruses 2008; 2(2):41-51; https://doi.org/10.1111/j.1750-2659.2008.00038.x
   PubMed Web of Science ®Google Scholar
• Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, Uematsu S, Kawai T, Akira S. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 2007; 179(7):4711-20; PMID:17878370; https://doi.org/10.4049/jimmunol.179.7.4711
   PubMed Web of Science ®Google Scholar
• Wang K, Holtz KM, Anderson K, Chubet R, Mahmoud W, Cox MM. Expression and purification of an influenza hemagglutinin–one step closer to a recombinant protein-based influenza vaccine. Vaccine 2006; 24(12):2176-85; PMID:16310896; https://doi.org/10.1016/j.vaccine.2005.11.005
   PubMed Web of Science ®Google Scholar
• Feshchenko E, Rhodes DG, Felberbaum R, McPherson C, Rininger JA, Post P, Cox MM. Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol 2012; 12:77; PMID:23110350; https://doi.org/10.1186/1472-6750-12-77
   PubMed Web of Science ®Google Scholar
• Goddard TD, Huang CC, Ferrin TE. Software extensions to UCSF chimera for interactive visualization of large molecular assemblies. Structure 2005; 13(3):473-82; PMID:15766548; https://doi.org/10.1016/j.str.2005.01.006
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31(2):455-61; PMID:19499576
   PubMed Web of Science ®Google Scholar